Author: Schett, Georg; Manger, Bernhard; Simon, David; Caporali, Roberto
Title: COVID-19 revisiting inflammatory pathways of arthritis Cord-id: ao0jesnj Document date: 2020_6_19
ID: ao0jesnj
Snippet: Coronavirus disease 2019 (COVID-19) is an infectious disease, caused by severe acute respiratory syndrome coronavirus 2, which predominantly affects the lungs and, under certain circumstances, leads to an excessive or uncontrolled immune activation and cytokine response in alveolar structures. The pattern of pro-inflammatory cytokines induced in COVID-19 has similarities to those targeted in the treatment of rheumatoid arthritis. Several clinical studies are underway that test the effects of inh
Document: Coronavirus disease 2019 (COVID-19) is an infectious disease, caused by severe acute respiratory syndrome coronavirus 2, which predominantly affects the lungs and, under certain circumstances, leads to an excessive or uncontrolled immune activation and cytokine response in alveolar structures. The pattern of pro-inflammatory cytokines induced in COVID-19 has similarities to those targeted in the treatment of rheumatoid arthritis. Several clinical studies are underway that test the effects of inhibiting IL-6, IL-1β or TNF or targeting cytokine signalling via Janus kinase inhibition in the treatment of COVID-19. Despite these similarities, COVID-19 and other zoonotic coronavirus-mediated diseases do not induce clinical arthritis, suggesting that a local inflammatory niche develops in alveolar structures and drives the disease process. COVID-19 constitutes a challenge for patients with inflammatory arthritis for several reasons, in particular, the safety of immune interventions during the pandemic. Preliminary data, however, do not suggest that patients with inflammatory arthritis are at increased risk of COVID-19.
Search related documents:
Co phrase search for related documents- activation infiltration and acute ards respiratory distress syndrome: 1, 2, 3, 4
- activation infiltration and acute phase: 1
- activation infiltration and lung disease: 1
- activation infiltration and lung inflammation: 1
- acute ards respiratory distress syndrome and adolescent child: 1
- acute ards respiratory distress syndrome and local production: 1, 2
- acute ards respiratory distress syndrome and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and lung inflammation contribute: 1, 2
- acute ards respiratory distress syndrome and lung inflammatory function: 1, 2, 3, 4, 5
- acute ards respiratory distress syndrome and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute phase and local production: 1
- acute phase and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute phase and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute phase and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute phase response and lung disease: 1
- acute phase response and lung inflammation: 1, 2
Co phrase search for related documents, hyperlinks ordered by date